Zombie lab [Equal Avatar Scale] vs StyleMe
Zombie lab [Equal Avatar Scale] currently leads with 772 concurrent players against 680. On all-time peak the record belongs to Zombie lab [Equal Avatar Scale] at 950 concurrent players, versus 812. Lifetime, Zombie lab [Equal Avatar Scale] has more visits (219.5M vs 8.8M). Full side-by-side history for Zombie lab [Equal Avatar Scale] and StyleMe is charted above.
Zombie lab [Equal Avatar Scale📏]
772
playing now
923 24h peak · 219.5M visits
VS
StyleMe
680
playing now
812 24h peak · 8.8M visits
Player count history
Zombie lab [Equal Avatar Scale]StyleMe
Head to head
| Metric | Zombie lab [Equal Avatar Scale] | StyleMe | Difference |
|---|---|---|---|
| Playing now | 772 | 680 | 92 |
| 24h peak | 923 | 812 | 111 |
| 24h average | 776 | 579 | 197 |
| 7-day peak | 925 | 812 | 113 |
| 7-day average | 798 | 434 | 364 (1.8×) |
| 30-day peak | 925 | 812 | 113 |
| All-time peak | 950 | 812 | 138 |
| 24h change | ▼ 10.2% | ▲ 31.3% | — |
| 7d change | — | ▲ 2.4% | — |
| Total visits | 219.5M | 8.8M | 210.6M (24.8×) |
| Visits (24h) | 103.4K | 46.7K | 56.7K (2.2×) |
| Visits (7d) | 157.4K | 293.7K | 136.3K (1.9×) |
| Favorites | 252.3K | 30.4K | 221.9K (8.3×) |
| Rating | 65.5% | 83.2% | — |
| Global rank (players) | #1,753 | #1,887 | of 8,283 |
| Trending score | -7.7 | 87.5 | — |
| Created | Apr 29, 2021 | Feb 18, 2026 | — |
| Genre | Survival | Shopping | — |
Other comparisons
Zombie lab [Equal Avatar Scale] vs Spectral Fades REMAKEZombie lab [Equal Avatar Scale] vs Clean CrewZombie lab [Equal Avatar Scale] vs Find and snipe Brainrot【update】Zombie lab [Equal Avatar Scale] vs Short Horror GamesZombie lab [Equal Avatar Scale] vs KPOP Random Play Dance (V3 Update)Zombie lab [Equal Avatar Scale] vs [W2] +1 Speed Phonk EscapeCompare two other games →
Both games are sampled on the same schedule and plotted on a shared time axis, so the comparison is like for like. Peaks, averages and growth come from RoVitals's own recorded history — 2 days for Zombie lab [Equal Avatar Scale], 13 for StyleMe.